Synthesis, characterization, and anticancer evaluation of N -(5,7-dimethyl-1,8-naphthyridin-2-yl) benzamide scaffolds

The development of novel anticancer agents remains a key focus in medicinal chemistry. We hypothesized that benzamide substitution of the 1,8-naphthyridine scaffold would enhance anticancer activity. In this study, we report a rapid, efficient, and environmentally benign green synthetic approach for the construction of a new series of N-(5,7-dimethyl-1,8-naphthyridin-2-yl)benzamide derivatives (5a-h). The synthesized compounds were characterized using standard spectroscopic techniques. All compounds were evaluated for their in vitro anticancer activity against three human cancer cell lines: MCF-7, A549, and Colo-205. The results revealed that the tested compounds exhibited significant anticancer activity. Among them, N-(5,7-dimethyl-1,8-naphthyridin-2-yl)-2-nitrobenzamide (5e) and 2-chloro-N-(5,7-dimethyl-1,8-naphthyridin-2-yl)benzamide (5c) showed the most potent activity, with IC50 values of 6.06 ± 0.14 μM (MCF-7), 8.36 ± 0.36 μM (A549), and 12.27 ± 0.73 μM (Colo-205) for compound 5e, and 8.06 ± 0.29 μM (MCF-7), 10.72 ± 0.49 μM (A549), and 15.39 ± 0.43 μM (Colo-205) for compound 5c, compared with the standard drug.

Authors

Institutions

Publication Details

Journal
Synthetic Communications
Published
2026-11-19
DOI
https://doi.org/10.1080/00397911.2026.2764714
Primary Topic
Heterocyclic Compound Synthesis and Bioactivity
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Synthesis, characterization, and anticancer evaluation of N -(5,7-dimethyl-1,8-naphthyridin-2-yl) benzamide scaffolds

Kavati Shireesha, Kumara Swamy Jella, Shaganti Venkatesh
Synthetic Communications
Heterocyclic Compound Synthesis and Bioactivity
article

Synthesis, characterization, and anticancer evaluation of N -(5,7-dimethyl-1,8-naphthyridin-2-yl) benzamide scaffolds

Kavati Shireesha, Kumara Swamy Jella, Shaganti Venkatesh
article en

Abstract

The development of novel anticancer agents remains a key focus in medicinal chemistry. We hypothesized that benzamide substitution of the 1,8-naphthyridine scaffold would enhance anticancer activity. In this study, we report a rapid, efficient, and environmentally benign green synthetic approach for the construction of a new series of N-(5,7-dimethyl-1,8-naphthyridin-2-yl)benzamide derivatives (5a-h). The synthesized compounds were characterized using standard spectroscopic techniques. All compounds were evaluated for their in vitro anticancer activity against three human cancer cell lines: MCF-7, A549, and Colo-205. The results revealed that the tested compounds exhibited significant anticancer activity. Among them, N-(5,7-dimethyl-1,8-naphthyridin-2-yl)-2-nitrobenzamide (5e) and 2-chloro-N-(5,7-dimethyl-1,8-naphthyridin-2-yl)benzamide (5c) showed the most potent activity, with IC50 values of 6.06 ± 0.14 μM (MCF-7), 8.36 ± 0.36 μM (A549), and 12.27 ± 0.73 μM (Colo-205) for compound 5e, and 8.06 ± 0.29 μM (MCF-7), 10.72 ± 0.49 μM (A549), and 15.39 ± 0.43 μM (Colo-205) for compound 5c, compared with the standard drug.

Synthetic Communications
Chaitanya (IN)
Heterocyclic Compound Synthesis and Bioactivity
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon